These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
674 related items for PubMed ID: 30636332
21. Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters. Jin J, Ruan X, Hua L, Tian X, Li Y, Wang L, Mueck AO. Gynecol Endocrinol; 2017 Sep; 33(9):694-697. PubMed ID: 28412857 [Abstract] [Full Text] [Related]
22. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women. Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Pratumvinit B, Sa-Nga-Areekul N. Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568 [Abstract] [Full Text] [Related]
23. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE]. Asanidze E, Khristesashvili J, Pkhaladze L, Barbakadze L. Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420 [Abstract] [Full Text] [Related]
24. Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women. Alhassan S, Elmugadam A, Elfadil GA, Abubaker N, Elfaki EM, Hamza A, Abdalhabib EK, Karar T. Int J Womens Health; 2023 Feb; 15():837-843. PubMed ID: 37275514 [Abstract] [Full Text] [Related]
25. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria]. Yang S, Ruan J, Huang W, Tan J, Zhang X, Feng X, Liu D, Fu J, Zhou L, Zhou M. Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768 [Abstract] [Full Text] [Related]
26. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome. Olszanecka-Glinianowicz M, Madej P, Owczarek A, Chudek J, Skałba P. Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474 [Abstract] [Full Text] [Related]
27. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus. Łebkowska A, Adamska A, Karczewska-Kupczewska M, Nikołajuk A, Otziomek E, Milewski R, Górska M, Wołczyński S, Kowalska I. Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579 [Abstract] [Full Text] [Related]
28. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles. Dewailly D, Alebić MŠ, Duhamel A, Stojanović N. Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785 [Abstract] [Full Text] [Related]
29. Anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome. Sathyapalan T, Al-Qaissi A, Kilpatrick ES, Dargham SR, Atkin SL. Clin Endocrinol (Oxf); 2018 Feb; 88(2):258-262. PubMed ID: 29144548 [Abstract] [Full Text] [Related]
30. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome. Köninger A, Sauter L, Edimiris P, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B. Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495 [Abstract] [Full Text] [Related]
31. The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women. Bungum L, Franssohn F, Bungum M, Humaidan P, Giwercman A. PLoS One; 2013 Mar; 8(9):e68223. PubMed ID: 24023708 [Abstract] [Full Text] [Related]
32. Advantages of Serum Anti-Müllerian Hormone as a Marker for Polycystic Ovarian Syndrome. Shi X, Peng D, Liu Y, Miao X, Ye H, Zhang J. Lab Med; 2019 Jul 16; 50(3):236-242. PubMed ID: 30535164 [Abstract] [Full Text] [Related]
33. AMH as part of the diagnostic PCOS workup in large epidemiological studies. Piltonen TT, Komsi E, Morin-Papunen LC, Korhonen E, Franks S, Järvelin MR, Arffman RK, Ollila MM. Eur J Endocrinol; 2023 Jun 07; 188(6):547-554. PubMed ID: 37294941 [Abstract] [Full Text] [Related]
34. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N. Hum Reprod; 2013 Mar 07; 28(3):762-9. PubMed ID: 23321213 [Abstract] [Full Text] [Related]
35. The diagnosis of PCOS in young infertile women according to different diagnostic criteria: the role of serum anti-Müllerian hormone. Casadei L, Fanisio F, Sorge RP, Collamarini M, Piccolo E, Piccione E. Arch Gynecol Obstet; 2018 Jul 07; 298(1):207-215. PubMed ID: 29802450 [Abstract] [Full Text] [Related]
36. Role of anti-Müllerian hormone and testosterone in follicular growth: a cross-sectional study. Lv PP, Jin M, Rao JP, Chen J, Wang LQ, Huang CC, Yang SQ, Yao QP, Feng L, Shen JM, Feng C. BMC Endocr Disord; 2020 Jul 08; 20(1):101. PubMed ID: 32641160 [Abstract] [Full Text] [Related]
38. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome. Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D. Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589 [Abstract] [Full Text] [Related]
39. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients. Aleyasin A, Aghahoseini M, Mokhtar S, Fallahi P. Acta Med Iran; 2011 Aug 01; 49(11):715-20. PubMed ID: 22131240 [Abstract] [Full Text] [Related]